Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Intracellular calcium stores and their release mechanisms are fundamental components of cellular signaling, primarily involving the endoplasmic reticulum (ER) and sarcoplasmic reticulum (SR). The release of sequestered calcium into the cytosol is predominantly mediated by two families of large tetrameric ion channels: the Inositol 1,4,5-trisphosphate receptors (IP3R) and the Ryanodine receptors (RyR) (StatPearls, 2023). These channels respond to various stimuli, such as second messengers or membrane depolarization, to trigger rapid increases in local calcium concentrations, which drive processes like muscle contraction, neurotransmission, and gene transcription (PubMed, PMC7271144). Dysregulation of these mechanisms, leading to pathological calcium leaks or impaired sequestration, is a hallmark of several diseases, including cardiac arrhythmias, skeletal muscle disorders, and neurodegeneration (UniProt, 2024). Therapeutic strategies often focus on stabilizing these channels or modulating their sensitivity to prevent pathological calcium overloads. For example, dantrolene is a clinically used antagonist of RyR1 employed to treat malignant hyperthermia by inhibiting uncontrolled calcium release (PubChem, CID 2952).
Modulation of the open-state probability of intracellular calcium release channels, specifically Ryanodine receptors and Inositol 1,4,5-trisphosphate receptors, to regulate the efflux of calcium ions from the endoplasmic or sarcoplasmic reticulum into the cytosol (StatPearls, 2023).
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Intracellular calcium release channels (Ryanodine receptor and Inositol 1,4,5-trisphosphate receptor) (RyR/IP3R).